Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer.

Li, Yilin; Gong, Jifang; Zhang, Qiyue; Lu, Zhihao; Gao, Jing; Li, Yanyan; Cao, Yanshuo; Shen, Lin

Li, Yilin; Gong, Jifang; Zhang, Qiyue; Lu, Zhihao; Gao, Jing; Li, Yanyan; Cao, Yanshuo; Shen, Lin.

Afiliação

Li Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Gong J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Zhang Q; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Lu Z; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Gao J; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Li Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Cao Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Shen L; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.

Br J Cancer ; 114(2): 138-45, 2016 Jan 19.

Article em En | MEDLINE | ID: mdl-26784122

Assuntos

Adenocarcinoma/tratamento farmacológico; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Neoplasias Hepáticas/tratamento farmacológico; Células Neoplásicas Circulantes; Neoplasias Peritoneais/tratamento farmacológico; Neoplasias Gástricas/tratamento farmacológico; Adenocarcinoma/sangue; Adenocarcinoma/metabolismo; Adenocarcinoma/secundário; Adulto; Idoso; Idoso de 80 Anos ou mais; Capecitabina/administração & dosagem; Cisplatino/administração & dosagem; Estudos de Coortes; Junção Esofagogástrica/patologia; Feminino; Humanos; Neoplasias Hepáticas/sangue; Neoplasias Hepáticas/metabolismo; Neoplasias Hepáticas/secundário; Estudos Longitudinais; Masculino; Pessoa de Meia-Idade; Compostos Organoplatínicos/administração & dosagem; Oxaliplatina; Paclitaxel/administração & dosagem; Neoplasias Peritoneais/sangue; Neoplasias Peritoneais/metabolismo; Neoplasias Peritoneais/secundário; Prognóstico; Estudos Prospectivos; Receptor ErbB-2/metabolismo; Neoplasias Gástricas/sangue; Neoplasias Gástricas/metabolismo; Neoplasias Gástricas/patologia; Trastuzumab/administração & dosagem; Resultado do Tratamento

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Peritoneais / Neoplasias Gástricas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Hepáticas / Células Neoplásicas Circulantes Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged80 Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google